Prophylactic contraceptives for HIV/AIDS

Human Reproduction Update

Volumn 5, Issue 5, 1999, Pages 506-514

  Uckun, Fatih M ^a   D'Cruz, Osmond J ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

AIDS; AZT; HIV; Spermicidal contraceptives; Viricidal microbicides; ZDV

Indexed keywords

5 BROMO 5,6 DIHYDRO 6 METHOXY 3' AZIDOTHYMIDINE 5' (4 BROMOPHENYL)METHOXYALANINYL PHOSPHATE; 5 BROMO 5,6 DIHYDRO 6 METHOXY 3' AZIDOTHYMIDINE 5' (4 METHOXYPHENYL)METHOXYALANINYL PHOSPHATE; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; DELAVIRDINE; DETERGENT; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; NONOXINOL 9; NUCLEOSIDE ANALOG; ORAL CONTRACEPTIVE AGENT; RNA DIRECTED DNA POLYMERASE; SPERMICIDAL AGENT; STAVUDINE; SURFACTANT; UNCLASSIFIED DRUG; WHI 01; WHI 02; WHI 03; WHI 04; WHI 06; WHI 08; WHI 09; WHI 10; WHI 11; WHI 12; ZALCITABINE; ZIDOVUDINE; ZIDOVUDINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL RESEARCH; CLINICAL TRIAL; CONTRACEPTION; CREAM; EPITHELIUM CELL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SPERMATOZOON MOTILITY; STRUCTURE ACTIVITY RELATION; TOPICAL DRUG ADMINISTRATION; UTERINE CERVIX DISEASE; VAGINA DISEASE; VAGINA FLORA; VAGINA PESSARY;

ANIMALS; ANTI-HIV AGENTS; CONDOMS; CONTRACEPTION; DRUG EVALUATION; DRUG EVALUATION, PRECLINICAL; FEMALE; HAPLORHINI; HIV; HIV INFECTIONS; HUMANS; IRRITANTS; MALE; MUCOUS MEMBRANE; RISK-TAKING; SEXUAL BEHAVIOR; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SPERMATOCIDAL AGENTS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS; VAGINA;

EID: 0032739391     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/5.5.506     Document Type: Review

References (71)

1. Alter, H.J., Eichberg, J.W., Masur, H. et al. (1984) Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science, 226, 549-552.
2. Avonts, D., Sercu, M., Heyerick, P. et al. (1990) Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex. Trans. Dis., 17, 23-29.
3. Augenbraun, M.H. and McCormack, W.M. (1994) Sexually transmitted diseases in HIV-infected persons. Infect. Dis. Clin. North Am., 8, 439-448.
4. Baba, M. Pauwels, R., Balzarini, J. et al. (1988) Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in viro. Proc. Natl. Acad. Sci. USA, 85, 6132-6136.
5. CDCP Update (1994) AIDS among women - United States, 1994. MMWR, 44, 81-84.
6. CDCP Update (1996) Mortality attributable to HIV infection among persons aged 25-44 years - United States, 1994. MMWR, 45, 121-125.
7. CDCP Update (1997) US HIV and AIDS cases reported through December 1996. HIV/AIDS Surveillance Report, 8, 1-33.
8. Celum, C.L. and Watts, D.H. (1996) HIV and women. In Spach, D.H. and Hooten, T.M. (eds), The HIV Manual. Oxford University Press, New York, USA, pp 120-127.
9. Chantier, E. (1992) Vaginal contraception: some current concerns. Br. J. Fam. Plann., 17, 118-119.
10. Cook, R.L. and Rosenberg, M.J. (1998) Do spermicides containing nonoxynol-9 prevent sexually transmitted infections? Sex. Transm. Dis., 25, 144-150.
11. Cookson, C. (1993) WHO to concentrate HIV strategy on vaginal microbicide. Br. Med. J., 307, 1375-1376.
12. Daly, C.C., Helling-Giese, G.E., Mati, J.K. and Hunter, D.J. (1994) Contraceptive methods and the transmission of HIV: Implications for family planning. Genitourin. Med., 70, 110-117.
13. D'Cruz, O.J., Venkatachalam, T.K., Zhu, Z. et al. (1998) Bromo-methoxy and aryl phosphate derivatives of azidothymidine are dual-function spermicides with potent anti-HIV activity. Biol. Reprod., 59, 503-515.
14. D'Cruz, O.J., Shih, M.-J., Yiv, S.H. et al. (1999a) Synthesis, characterization, and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities. Mol. Hum. Reprod., 5, 421-432.
15. D'Cruz, O.J. and Uckun, F.M. (1999b) Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-action spermicides with potent anti-HIV activity. Biol. Reprod., 60, 1419-1428.
16. D'Cruz, O.J., Zhu, Z., Yiv, S.H. et al. (1999c) WHI-05, a novel bromo-methoxy substituted aryl phosphate derivative of zidovudine ia a dual-action spermicide with potent anti-HIV activity. Contraception, in press.
17. Elias, C.J. and Heise, L.L. (1994) Challenges for the development of female-controlled vaginal microbicides. AIDS, 8, 1-9.
18. Elias, C. and Heise, L.L. (1995) Nonoxynol-9: the need for policy in the face of uncertainty. [Letter.] AIDS, 9, 311-312.
19. Gosselin, R.E, Smith, R.P., Hodge, H.C. and Braddock, J.E. (1984) Clinical Toxicology of Commercial Products. 5th edn. Williams & Wilkins, Baltimore, USA.
20. Hicks, D.R., Martin, L.S., Getchell, J.P. et al. (1985) Inactivation of HTLV-III/LAW infected cultures of normal lymphocytes by nonoxynol-9 in vitro. Lancet, ii, 1422-1433.
21. Hira, S.K., Feldblum, P.J., Kamanga, J. et al. (1997) Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int. J. STD. AIDS, 8, 243-250.
22. Hooten, T.M., Hillier, S., Johnson, C. et al. (1991) Escherichia coli bacteriuria and contraceptive method. J. Am. Med. Assoc., 265, 64-69.
23. Ickovics, J.R. and Rodin, J. (1992) Women and AIDS in the United States: epidemiology, natural history, and mediating mechanisms. Health Psychol., 11, 1-16.
24. Keenlyside, R.A., Johnson, A.M. and Mabey, D.C.W. (1993) The epidemiology of HIV-1 infection and AIDS in women. AIDS, 1, S83-S90.
25. Kohlstaedt, L.A., Wang, J., Friedman, J.M. et al. (1992) Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science, 256, 1783-1790.
26. Kreiss, J., Ngugi, E., Holmes, K. et al. (1992) Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. J. Am. Med. Assoc., 268, 477-482.
27. Krieger, J.N., Coombs, R.W., Collier, A.C. et al. (1991) Recovery of human immunodeficiency virus type 1 from semen: minimal impact of stage of infection and current antiviral chemotherapy. J. Infect. Dis., 163, 386-388.
28. Kulig, J.W. (1989) Adolescent contraception: nonhormonal methods. Ped. Clinic. North Am., 36, 717-730.
29. Lange, J.M.A., Karam, M. and Piot, P. (1993) Boost for vaginal microbicides against HIV. Lancet, 341, 1356-1359.
30. Mai, A., Artica, M., Sbardella, G. et al. (1997) Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: Novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series. J. Med. Chem., 40, 1447-1454.
31. Marina, S., Marina, F., Alcolea, R. et al. (1998) Human Immunodeficiency virus type 1-serodiscordent couples can bear healthy children after undergoing intrauterine insemination. Fertil. Steril., 70, 35-39.
32. Mati, J.K., Hunter, D.F., Maggwa, B.N. and Tukei, P.M. (1995) Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int. J. Obstet. Gynecol. 48, 61-67.
33. McClure, M.O., Moore, J.P., Blane, D.F. et al. (1992) Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res. Hum. Retroviruses, 8, 19-26.
34. McGuigan, C., Kinchington, D., Nicholls, S.R. et al. (1993a) Kinase bypass: a new strategy for anti-HIV drug design. Biorg. Med. Chem. Lett., 3, 1207-1210.
35. McGuigan, C., Pathirana, R.N., Balzarini, J. and De Clerecq, E. (1993b) Intracellular delivery of bioactive ZDV nucleotides by aryl phosphate derivatives of ZDV. J. Med. Chem., 36, 1048-1052.
36. McGuigan, C., Cahard, D., Sheeka, H.M. et al. (1996) Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite. J. Med. Chem., 39, 1748-1753.
37. Mitsuya, H., Yarchoan, R. and Broder, S. (1990) Molecular targets for AIDS therapy. Science, 249, 1533-1544.
38. Mitsuya, H., Weinhold, K.J., Furman, P.A. et al. (1985) 3′-Azido-3-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc. Natl. Acad. Sci. USA, 82, 7096-7100.
39. Niruthisard, S.R., Roddy, E. and Chutivongse, S. (1991) The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex. Transm. Dis., 18, 176-179.
40. OTC Panel (1980) Vaginal contraceptive drug products for over-the-counter human use. Fed. Reg., 45, 82014-82049.
41. Padian, N., Marquis, L., Francis, D.P. et al. (1987) Male-to-female transmission of human immunodeficiency virus. J. Am. Med. Assoc., 258, 788-790.
42. Patton, D.L., Sweeney, Y.C., Rabe, L.K. and Hillier, S.L. (1996) The vaginal microflora of pig-tailed macaques and the effects of chlorhexidine and benzylkonium on the ecosystem. Sex. Trans. Dis., 23, 489-193.
43. Pauwels, R., Andries, K., Desmyter, J. et al. (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature, 343, 470-474.
44. Phillips, D.M. (1994) The role of cell-to-cell transmission in HIV infection. AIDS, 8, 719-731.
45. Phillips, D.M. and Pearce-Pratt, R. (1996) Sulfatedpolysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1. Biol. Reprod., 54, 173-182.
46. Polsky, B. Baron, P.A., Gold, J.W. et al. (1988) In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. Lancet, i, 1456.
47. Potts, M. (1994) The urgent need for a vaginal microbicide in the prevention of HIV transmission. [Editorial.] Am. J. Public. Health. 84, 890-891.
48. Quayle, A.J., Xu, C., Mayer, K.H. and Anderson, D.J. (1997) T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis., 176, 960-968.
49. Quinn, T.C. (1996) Global burdern of the HIV pandemic. Lancet, 348, 99-106.
50. Raymond, E. and Dominik, R. (1999) Contraceptive effectiveness of two spermicides: a randomized trial. Obstet. Gynecol. 93, 896-903.
51. Rekart, M.L. (1992) The toxicity and local effects of the spermicide nonoxynol-9. J. Acquir. Immune Defic. Syndr., 5, 425-421.
52. Ren, J., Esnouf, R., Garman, E. et al. (1995) High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol., 2, 293-302.
53. Roddy, R.E., Cordero, M., Cordero, C. and Fortney, J. A. (1993) A dosing of nonoxynol-9 and genital irritation. Int. J. STD & HIV, 4, 165-170.
54. Roddy, R.E., Zeking, L., Ryan, K.A. et al. (1998) A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N. Engl. J. Med., 339, 504-510.
55. Rosenstein, I.J., Stafford, M.K., Kitchen, V.S. et al. (1998) Effect of normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J. Infect. Dis., 177, 1386-1390.
56. Royce, R.A., Sena, A., Cates, W. Jr. and Cohen, M.S. (1997) Sexual transmission of HIV. N. Engl. J. Med., 336, 1072-1078.
57. Schacker, T., Ryncarz, A.J., Goddard, J. et al. (1998) Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. J. Am. Med. Assoc., 280, 61-66.
58. Schill, W.B. and Wolf, H.H. (1981) Ultrastructure of human spermatozoa in the presence of the spermicide nonoxynol-9 and a vaginal contraceptive containing nonoxynol-9. Andrologia, 13, 42-49.
59. Scofield, V.L., Rao, B., Broder, S. et al. (1994) HIV interaction with sperm. AIDS, 8, 1733-1736.
60. Smerdon, S.J., Jager, J., Wang, J. et al. (1994) Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA, 91, 3911-3915.
61. Stafford, M.K., Ward, H., Flanagan, A. et al. (1998) A safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 17, 327-331.
62. Stamm, W.E., Handsfield, H.H., Rompalo, A.M. et al. (1988) The association between genital ulcer disease and acquisition of HIV infection in homosexual men. J. Am. Med. Assoc., 260, 1429-1433.
63. Trussell, J. and Trost, K. (1987) Contraceptive failure in the United States: a critical review of the literature. Stud. Fam. Plann., 18, 237-283.
64. Vig, R., Mao, C., Venkatachalam, T.K. et al. (1998a) Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg. Med. Chem., 6, 1789-1797.
65. Vig, R., Mao, C., Venkatachalam, T.K. et al. (1998b) 5-Alkyl-2((methylthiomethyl)thio)-6-(benzyl)-pyridmidin-4-(1H)-o nes as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series. Bioorg. Med. Chem. Letters, 8, 1461-1466.
66. Wang, L., Morin, K.W., Kumar, R. et al. (1996) In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-6-methoxy(or ethoxy)-5,6-dihydro-3′-azido-3′-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3′-deoxythymidine. J. Med. Chem., 39, 826-833.
67. Ward, J.W. and Duchin, J.S. (1997) The epidemiology of HIV and AIDS in the United States. AIDS Clin. Rev., 98, 1-45.
68. Weir, S.S., Roddy, R.E., Zeking, L. and Feldblum, P.J. (1995) Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Genitourin. Med., 71, 78-81.
69. Wilborn, W.H., Hahn, D.W. and McGuire, J.J. (1983) Scanning electron microscopy of human spermatozoa after incubation with the spermicide nonoxynol-9. Fertil. Steril., 39, 717-719.
70. Wittkowski, K.M. (1995) The potential of nonoxynol-9 for the prevention of HIV infection reconsidered (letter). AIDS, 9, 310.
71. Zhang, H., Dornadula, G., Beumont, M. et al. (1998) Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N. Engl. J. Med., 339, 1803-1809.